An Open labelled Randomized Comparative Study to evaluate the efficacy of Roghan-e-Zarareeh & Leech Therapy in Dau’salab (Alopecia Areata)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- Change in Severity of Alopecia Tool (SALT) score indicating reduction in number and size of alopecia patches from baseline to end of treatment.
研究概览
简要总结
Alopecia areata is an autoimmune disorder that can lead to unpredictable hair loss. Scientists believe the cause is genetic, as it tends to run in families. Alopecia Areata is a type of non-scarring alopecia that effects males and females equally and occurs in both children and adults. There is currently no cure for alopecia areata, although there are some forms of treatment that can be suggested by doctors to help hair re-grow more quickly. Some have compared alopecia areata to vitiligo, an autoimmune skin disease in which the body attacks melanin-producing cells, leading to white patches. Research suggests that these two conditions may share a similar pathogenesis, with similar types of immune cells and cytokines driving the diseases and common genetic risk factors.
According to Unani Dau’salab , Daul’Hayya meaning the disease of Fox and Snake for those reasons of resemblances of these two animals which often suffers from this condition. According to IBN-E-SINA, a legendary Unani Physician, the disease can occur in any part of body but scalp, face and eyebrows are the commonest sites.
According to UNANI: - The disease is commonly characterized by the accumulation of morbid humours. It has been considered to be caused by infection either directly or as a consequence of remote ‘focus of infection’. Viral infection is the most common cause of infection especially Cytomegalovirus, Epstein Barr virus, Swine flu virus etc. The antigen of these viruses is present in blood for a long time thus causing Fasad-e-Dam. These antigens have their antibodies circulating in blood, sometimes they cause exaggerated immune response in body, thus Alopecia Areata is considered mainly autoimmune disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Clinically diagnosed cases of Dau’salab (Alopecia Areata) with open follicular pores (orange-surface appearance).
- •2.Age between 18 and 50 years, either sex.
- •3.Patients willing to give written informed consent and comply with study protocol.
- •4.Hb more than 8 gdL.
排除标准
- •1.Patients with androgenic alopecia, tinea capitis, traction alopecia or telogen effluvium.
- •2.Patients with hereditary alopecia.
- •3.Patients with diabetes mellitus.
- •5.Patients with bleeding disorders.
- •6.Patients with hemoglobin less than 8 g/dL.
- •7.Patients with alopecia involving eyebrows or eyelashes.
- •8.Patients with closed follicular pores, scarring or fibrosis of scalp.
- •9.Patients with other systemic illness affecting hair growth.
结局指标
主要结局
Change in Severity of Alopecia Tool (SALT) score indicating reduction in number and size of alopecia patches from baseline to end of treatment.
时间窗: Baseline and at the end of treatment period.
次要结局
未报告次要终点
研究者
DR GORUKALLU ABBAS AHMED
GOVERNMENT NIZAMIA TIBBI COLLEGE
